We are live on ! Find out more
TRIM

Thompson Rubinstein Investment Management Portfolio holdings

AUM $311M
1-Year Est. Return 11.71%
This Fund
S&P 500
This Quarter Est. Return
+5.53%
1 Year Est. Return
+11.71%
3 Year Est. Return
+42.81%
5 Year Est. Return
+48.65%
10 Year Est. Return
AUM
$287M
AUM Growth
+$15M
Cap. Flow
+$1.36M
Cap. Flow %
0.47%
Top 10 Hldgs %
39.8%
Holding
79
New
Increased
21
Reduced
19
Closed

Top Buys

Rank Stock Value
1
NVS icon
Novartis
NVS
+$904K
2
SLB icon
SLB Ltd
SLB
+$821K
3
QEP
QEP RESOURCES, INC.
QEP
+$486K
4
DVN icon
Devon Energy
DVN
+$234K
5
T icon
AT&T
T
+$86.4K

Top Sells

Rank Stock Value
1
KMPR icon
Kemper
KMPR
+$1.17M
2
COLM icon
Columbia Sportswear
COLM
+$148K
3
GLW icon
Corning
GLW
+$37K
4
EW icon
Edwards Lifesciences
EW
+$34.8K
5
NOV icon
NOV
NOV
+$33.3K

Sector Composition

Rank Sector Weight
1 Healthcare 28.55%
2 Industrials 23.26%
3 Technology 15.96%
4 Energy 9.68%
5 Consumer Staples 7.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USB icon
51
US Bancorp
USB
$99.2B
$1.29M 0.45%
24,037
CAT icon
52
Caterpillar
CAT
$388B
$1.26M 0.44%
10,123
DVN icon
53
Devon Energy
DVN
$47.1B
$1.19M 0.42%
32,475
+7,230
+29% +$234K
SPXC icon
54
SPX Corp
SPXC
$10.8B
$1.11M 0.39%
37,727
FLOW
55
DELISTED
SPX FLOW, Inc.
FLOW
$1.03M 0.36%
26,722
T icon
56
AT&T
T
$162B
$1.03M 0.36%
34,751
+3,045
+10% +$86.4K
BIVV
57
DELISTED
Bioverativ Inc. Common Stock
BIVV
$950K 0.33%
16,638
-64
-0.4% -$3.75K
VZ icon
58
Verizon
VZ
$193B
$923K 0.32%
18,646
+209
+1% +$9.83K
BWA icon
59
BorgWarner
BWA
$13.9B
$750K 0.26%
16,625
+568
+4% +$23.2K
MRK icon
60
Merck
MRK
$315B
$713K 0.25%
11,663
+838
+8% +$50.8K
SVU
61
DELISTED
SUPERVALU Inc.
SVU
$708K 0.25%
32,550
-2
-0% -$44
CDK
62
DELISTED
CDK Global, Inc.
CDK
$642K 0.22%
10,180
BMY icon
63
Bristol-Myers Squibb
BMY
$131B
$612K 0.21%
9,600
AGN
64
DELISTED
Allergan plc
AGN
$604K 0.21%
2,946
JPM icon
65
JPMorgan Chase
JPM
$942B
$597K 0.21%
6,255
TRV icon
66
Travelers Companies
TRV
$80B
$549K 0.19%
4,479
MRSH
67
Marsh
MRSH
$91.8B
$548K 0.19%
6,543
VREX icon
68
Varex Imaging
VREX
$525M
$474K 0.17%
14,000
-174
-1% -$5.44K
JCI icon
69
Johnson Controls International
JCI
$92.5B
$461K 0.16%
11,432
WST icon
70
West Pharmaceutical
WST
$24.7B
$385K 0.13%
4,000
ORCL icon
71
Oracle
ORCL
$412B
$382K 0.13%
7,900
ING icon
72
ING
ING
$102B
$376K 0.13%
20,388
RTX icon
73
RTX Corp
RTX
$298B
$371K 0.13%
5,085
ED icon
74
Consolidated Edison
ED
$39.5B
$357K 0.12%
4,419
EW icon
75
Edwards Lifesciences
EW
$51.4B
$318K 0.11%
8,718
-912
-9% -$34.8K

Similar funds

Thompson Rubinstein Investment Management's Q3 2017 Portfolio in Review

As of Q3 2017, Thompson Rubinstein Investment Management held 79 positions worth $287M, up 5.5% from $272M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Trading was light in Q3 2017: portfolio turnover was 0%. Thompson Rubinstein Investment Management opened no new positions and made no exits, leaving the 79-position portfolio largely intact.

By sector, the portfolio is most concentrated in Healthcare at 29% of assets, down from 29% a quarter earlier, followed by Industrials and Technology.

  • Thompson Rubinstein Investment Management added most to Novartis in Q3 2017, an estimated $904K increase.
  • Thompson Rubinstein Investment Management's biggest Q3 2017 reduction was Kemper, cutting an estimated $1.17M.
  • Thompson Rubinstein Investment Management's ten largest holdings make up 40% of its $287M portfolio in Q3 2017.
  • Thompson Rubinstein Investment Management opened 0 new positions and closed 0 in Q3 2017.
  • Thompson Rubinstein Investment Management's portfolio value rose 5.5% quarter-over-quarter to $287M.

Based on Thompson Rubinstein Investment Management's 13F filing for Q3 2017, filed 12 Oct 2017.